Skip to main content

Determination of Reduced and Oxidized Coenzyme Q10 in Canine Plasma and Heart Tissue by HPLC-ECD: Comparison with LC-MS/MS Quantification.

Coenzyme Q10 (Q10) plays an important role in mammals for energy production in the mitochondria, and as a powerful antioxidant. Oxidation Ratio (% oxidized in relation to the amount of Q10) has been proposed as an important biomarker. 

An HPLC-ECD method is sensitive and Equine Serum Albumin reproducible developed for the determination of reduced and oxidized Q10 in dog plasma and heart tissue. chromatographic separation is achieved within 10 minutes by using the column Waters Nova-pak C18 and the mobile phase with lithium perchlorate in ethanol / methanol / 2-propanol. validation show satisfactory results. a very good linear correlation was found (r 2> 0.9997), intra- and inter-day precision were below 6.5% (n = 5) and the recovery is between 89 and 109% (n = 5). 

The sensitivity is expressed as the Lower Limit Quantification (LLOQ) was 10 nM. acceptable stability of both samples extracted and un-extracted observed. Total plasma concentration range Q10 is found between 0.64 and 1.24 ug / mL. Comparison with the method of LC-MS / MS forward showing a correlation of r = 0.85 to reduce Q10 and r = 0.60 for the oxidized Q10 (N = 17). However, the average yield is about 30% lower for ubiquinol using LC-MS / MS compared with HPLC-ECD analysis. Two methods are therefore not considered to be interchangeable
Determination of Reduced and Oxidized Coenzyme Q10 in Canine Plasma and Heart Tissue by HPLC-ECD: Comparison with LC-MS/MS Quantification.

coagulation factor activity in units nonleukoreduced dog leukoreduced and fresh-frozen plasma.


To evaluate the coagulation factors in units leukoreduced (LR) and nonleukoreduced (non-LR) dog fresh-frozen plasma (cFFP) 0.8 sound research dogs.In crossover study, dogs were randomly assigned to 1 of 2 groups of which the blood was collected and whether or not to undergo leukoreduction. After a recovery period ≥ 28 days, dogs were switching between protocols.

 After each collection, blood samples were centrifuged, and cFFP was stored frozen for later analysis comparative coagulation factors, antithrombin and protein C activity (reported as a percentage of the appropriate ratio of activities specified in the standard dog plasma collected); prothrombin and activated partial thromboplastin time; and fibrinogen concentration.

There no significant difference was detected Feline Plasma between the results for LR cFFP, compared with those for non-LR cFFP.Although there are variations between the residual activity of coagulation factors in the LR and non-LR cFFP, variations and differences are considered unlikely impact properties cFFP LR transfused to coagulation factor replacement in dogs.

 However, because of the small sample size and high variability results in this study, additional studies with sample sizes are needed for definitive conclusions about the effects of leukoreduction on coagulation factors in cFFP and to develop treatment guidelines for use LR cFFP in dogs with congenital and acquired coagulopathies.
Labels:

Comments

Post a Comment

Popular posts from this blog

A placebo-controlled study comparing the efficacy of intra-articular injections of hyaluronic acid and a novel hyaluronic acid-platelet-rich plasma conjugate in a canine model of osteoarthritis.

The purpose of this study was to assess the efficacy of intra-articular injection of hyaluronic acid (HA) and a novel, where the conjugate of HA with fibrinogen autologous be platelet rich plasma (HA-PRP) in a canine model of osteoarthritis (OA) METHOD : Twelve  Donkey Serum beagle dogs underwent unilateral resection of the cranial cruciate ligament (CrCl) of the joint crippling. clinical signs and radiographic OA was confirmed in all dogs 8 weeks after CrCl resection and before treatment.  The dogs were randomized into three groups: saline (n = 4), HA (n = 4), and HA-PRP (n = 4). Each dog receives intra-articular injections of each substance into the affected joint in a pre-determined point in time. The dogs were assessed for adverse events during 3 days after each injection and for lameness, pain, range of motion, kinetics, and radiographic OA severity before treatment and 3 months after injection.  OA severity as determined by radiographic examination did not differ s...
Post a Comment
Read more

Assessment of the Efficacy of Platelet-Rich Plasma in the Treatment of Traumatic Canine Fractures.

Role of platelet rich plasma (PRP) to promote fracture healing has not been stated clearly. The aim of this prospective clinical study was to evaluate the effectiveness of plasma rich in growth factors (PRGF, derivate PRP) in the treatment of bone fracture occurs naturally in dogs.  With the goal, sixty-five-dog with  Goat Serum a radius / ulna or tibia / fracture of the fibula were randomly divided into two groups (PRGF and saline solution (SS) group) and examined at days 0, 7, 14, 21, 28, 35, 42, 49, 56, 60, 63, 70, 120, and 180.  All fractures treated with external skeletal fixation, and pain is controlled with carprofen. Healing was evaluated by physical examination, limb function, radiographic, and by Likert-type questionnaires owner satisfaction. A more rapid healing of fractures observed in PRGF group, with a statistically significant difference against the SS. Swelling at the site of fracture was significantly greater at 14 and 28 days in animals injected with t...
Post a Comment
Read more